Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Goulden

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Haematology|May 4, 2002
Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALLNick Goulden, Colin Steward
British Journal of Haematology|July 20, 2006
Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is nowNick Goulden, Paul Virgo, David Grimwade
The Lancet. Oncology|September 5, 2014
MRD stratification for paediatric ALLChris Mitchell, Nick Goulden, Ajay Vora
Clinical Dysmorphology|May 10, 2012
One in 10 million: a case of cleidocranial dysplasia and acute lymphoblastic leukaemia--more than just a coincidence?Alice Gardham, Elizabeth Forsythe, Nick Goulden
The Pediatric Infectious Disease Journal|February 13, 2002
Streptococcal fasciitis causing phlegmasia cerulea dolensMartin Billington, Nick Goulden, Jenny Tyrrell, et al.
British Journal of Haematology|June 24, 2009
Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?Keith Sibson, Colin Steward, John Moppett, et al.
British Journal of Haematology|March 6, 2010
Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safeAmrana Qureshi, Chris Mitchell, Sue Richards, et al.
British Journal of Haematology|October 11, 2011
Alpha interferon augments the graft-versus-leukaemia effect of second stem cell transplants and donor lymphocyte infusions in high-risk paediatric leukaemiasNichola Cooper, Kanchan Rao, Nick Goulden, et al.
Blood|February 21, 2004
Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposureBrigitta Versluys, Rajat Bhattacharaya, Colin Steward, et al.
British Journal of Haematology|December 20, 2015
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003Rachael Hough, Clare Rowntree, Nick Goulden, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|May 4, 2002
Clinical relevance of MRD in children undergoing allogeneic stem cell transplantation for ALLNick Goulden, Colin Steward
British Journal of Haematology|July 20, 2006
Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is nowNick Goulden, Paul Virgo, David Grimwade
The Lancet. Oncology|September 5, 2014
MRD stratification for paediatric ALLChris Mitchell, Nick Goulden, Ajay Vora
Clinical Dysmorphology|May 10, 2012
One in 10 million: a case of cleidocranial dysplasia and acute lymphoblastic leukaemia--more than just a coincidence?Alice Gardham, Elizabeth Forsythe, Nick Goulden
The Pediatric Infectious Disease Journal|February 13, 2002
Streptococcal fasciitis causing phlegmasia cerulea dolensMartin Billington, Nick Goulden, Jenny Tyrrell, et al.
British Journal of Haematology|June 24, 2009
Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?Keith Sibson, Colin Steward, John Moppett, et al.
British Journal of Haematology|March 6, 2010
Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safeAmrana Qureshi, Chris Mitchell, Sue Richards, et al.
British Journal of Haematology|October 11, 2011
Alpha interferon augments the graft-versus-leukaemia effect of second stem cell transplants and donor lymphocyte infusions in high-risk paediatric leukaemiasNichola Cooper, Kanchan Rao, Nick Goulden, et al.
Blood|February 21, 2004
Prophylaxis with defibrotide prevents veno-occlusive disease in stem cell transplantation after gemtuzumab ozogamicin exposureBrigitta Versluys, Rajat Bhattacharaya, Colin Steward, et al.
British Journal of Haematology|December 20, 2015
Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003Rachael Hough, Clare Rowntree, Nick Goulden, et al.
Pageof 3